Cargando…
Screening Novel Molecular Targets of Metformin in Breast Cancer by Proteomic Approach
Metformin is a commonly prescribed antihyperglycemic drug, and has been investigated in vivo and in vitro for its effect to improve the comorbidity of diabetes and various types of cancers. Several studies investigated the therapeutic mechanisms of metformin on cancer cells, but the exact mechanism...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650619/ https://www.ncbi.nlm.nih.gov/pubmed/29085821 http://dx.doi.org/10.3389/fpubh.2017.00277 |